Hemp Inc (HEMP)

[albert]

HPB-Artery Klenz to serve as an oral supplement for heart disease. HUTCHINSON, Kan. - PRNewswire-FirstCall - May 19
HUTCHINSON, Kan., May 19 /PRNewswire-FirstCall/ -- HEE Corporation Inc. (OTC:HCCF) (BULLETIN BOARD: HCCF) announced today the acquisition of a natural oral chelate, or detoxifying agent, designed to inhibit and repair the damaging effects of heart disease. Tentatively named "HPB-Artery Klenz," the metabolic product is intended to offer a preventative solution to cardiovascular dysfunction and provide a potential alternative to coronary bypass surgery.

Approximately 40 million Americans suffer from heart disease and nearly 300,000 undergo coronary artery bypass surgery every year. According to HEE Corporation President Radley Brooks, "The addition of Artery Klenz to our product mix will allow the consumer a safe and inexpensive formula for dealing with potential heart disease both before and after it becomes problematic and will help minimize the need for invasive surgical procedures."

Manufactured in the United States, HPB-Artery Klenz, "not only has the ability to remove calcium and plaque deposits from narrowed blood vessels, but will also improve metabolic and circulatory functions by removing various toxic metals such as iron, lead, mercury and cadmium," said Brooks.

Chelation is a metabolic medical treatment that has the capability of reducing high blood pressure and cholesterol, at the same time helping to eliminate arterial plaque, not only in the heart, but throughout the body. Working in concert with traditional medical techniques and remedies, HPB- Artery Klenz shows promise in making significant strides in the prevention and repair of the damaging effects of heart disease.

In April, HEE Corporation announced the launch of its web-based product sales and information site, http://www.hpb84.net/ . The exclusive international distributor of HPB-84, a nutriceutical developed in India, HEE Corporation has spent the past year testing and developing the promising nutriceutical for Type II diabetes. Similarly, HEE Corporation will conduct a thorough testing of HPB-Artery Klenz as the next addition to its product mix of natural products developed for metabolic syndrome. At the conclusion of such scientifically stringent testing, HPB-Artery Klenz will join the HEE Corporation family of naturopathic metabolic remedies for the treatment of catastrophic diseases.

About HEE
HEE's headquarters is based in Hutchinson, Kansas.

Forward-Looking Statements:
Statements in this release that are "forward-looking statements" are based on current expectations and assumptions that are subject to risks and uncertainties. Actual results could differ materially because of factors such as: entry into markets with vigorous competition, market acceptance of new products and services, continued acceptance of existing products and services, changes in licensing programs, product price discounts, delays in product development and related product release schedules, sales channel disruption such as the bankruptcy of a major distributor, and reliance on sole source suppliers for key components that could result in delays in product delivery. Also, any of which may cause revenues and income to fall short of anticipated levels; technological shifts; the ability to have access to distribution channels that are controlled by third parties; the risk of unanticipated increased costs; the continued ability to protect the company's intellectual property rights; adverse effects on our business that might result if an unauthorized disclosure of a significant portion of our formula were to occur; the ability to obtain on acceptable terms the right to incorporate in the company's products and services; changes in product and service mix; maturing product life cycles; product sale terms and conditions; the risk that actual or perceived vulnerabilities in our products could adversely affect our revenues; implementation of operating cost structures that align with revenue growth; unavailability of insurance; uninsured losses; adverse results in litigation; unanticipated tax liabilities; the effects of terrorist activity and armed conflict such as disruptions in general economic activity and changes in our operations and security arrangements; the effects of a major earthquake, cyber-attack or other catastrophic event that results in the destruction or disruption of any of our critical business or information technology systems; the level of corporate information technology spending and changes in general economic conditions that affect demand; currency fluctuations; and financial market volatility or other changes affecting the value of our investments that may result in a reduction in carrying value and recognition of losses including impairment charges. Note to editors: If you are interested in viewing additional information on HEE Corp, please visit the HEE Corp web page at http://www.hee-corp.com/ on HEE Corp's information pages. Web links, telephone numbers and titles were correct at time of publication, but may since have changed. Shareholder and financial information is available at http://www.hee-corp.com/ .

Contact Information
Darci Brooks
HEE Corporation
http://www.hee-corp.com/
620-663-3333
HEE Corporation Inc.



Albert